These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2500673)

  • 1. Biological equivalent dose prediction in pion irradiation using pion star density and the mixed beam lesion additivity model.
    Shirato H
    Phys Med Biol; 1989 Jun; 34(6):769-76. PubMed ID: 2500673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies of the TRIUMF pion therapy beam.
    Skarsgard LD; Douglas BG; Denekamp J; Chaplin DJ; Lam GK; Harrison RW; Kornelsen RO; Palcic B
    Radiat Res Suppl; 1985; 8():S135-44. PubMed ID: 3937169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the use of the pion stopping distribution and the lesion additivity concept for the calculation of effective doses in pion treatment planning.
    Lam GK
    Phys Med Biol; 1990 Jun; 35(6):731-40. PubMed ID: 2114647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell survival over the depth profile after irradiation with a negative pion beam.
    Tremp J; Blattmann H; Fritz-Niggli H
    Radiat Environ Biophys; 1979 Aug; 16(3):267-72. PubMed ID: 504556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian cell survival studies characterizing multiport negative pi-meson irradiation with the Stanford Medical Pion Generator (SMPG).
    Li GC; Fessenden P; Hahn GM; Fisher G; Luxton G; Bagshaw MA
    Int J Hyperthermia; 1994; 10(3):361-70. PubMed ID: 7930802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interpretation of some biological results obtained in range-modulated negative pion beams.
    Brenner DJ; Dicello JF; Zaider M
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):121-6. PubMed ID: 7061246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations of pion RBE in a volume with an asymmetric beam configuration.
    Rao KR; Blattmann H; Fritz-Niggli H
    Strahlenther Onkol; 1987 Nov; 163(11):739-41. PubMed ID: 3686337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pions for radiotherapy at TRIUMF.
    Skarsgard LD; Henkelman RM; Eaves CJ
    J Can Assoc Radiol; 1980 Mar; 31(1):3-12. PubMed ID: 7364844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical studies of the negative pi-meson beam at TRIUMF.
    Skarsgard LD; Henkelman RM; Lam GK; Palcic B; Poon MN
    Radiat Environ Biophys; 1979 Aug; 16(3):193-204. PubMed ID: 116303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the use of effective dose in the treatment planning of high linear-energy-transfer radiation.
    Lam GK
    Med Phys; 1989; 16(5):687-91. PubMed ID: 2509863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different stopping volumes of clinical pion beams at TRIUMF on the mouse small intestine.
    Saito T; Chaplin DJ; Lam GK; Skarsgard LD
    Radiat Res; 1989 Jan; 117(1):8-20. PubMed ID: 2492379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OER and RBE for negative pion beams of different peak widths.
    Raju MR; Amols HI; Bain E; Carpenter SG; Cox RA; Robertson JB
    Br J Radiol; 1979 Jun; 52(618):494-8. PubMed ID: 465928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of mouse epidermis to fractionated doses of pi mesons.
    Chaplin DJ; Douglas BG; Grulkey W; Skarsgard LD; Lam G; Denekamp J
    Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1199-208. PubMed ID: 3610708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent absence of a proton beam dose rate effect and possible differences in RBE between Bragg peak and plateau.
    Matsuura T; Egashira Y; Nishio T; Matsumoto Y; Wada M; Koike S; Furusawa Y; Kohno R; Nishioka S; Kameoka S; Tsuchihara K; Kawashima M; Ogino T
    Med Phys; 2010 Oct; 37(10):5376-81. PubMed ID: 21089773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uniform depth dose distribution for biological irradiation using negative pions.
    Lam GK; Henkelman RM; Harrison RW; Skarsgard LD; Palcic B
    Phys Med Biol; 1979 Nov; 24(6):1243-9. PubMed ID: 119235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical model estimation of relative biological effectiveness for proton beam therapy.
    Chen Y; Ahmad S
    Radiat Prot Dosimetry; 2012 Apr; 149(2):116-23. PubMed ID: 21593038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of relative biological effectiveness of the 70 MeV proton beam at TRIUMF using Chinese hamster V79 cells and the high-precision cell sorter assay.
    Wouters BG; Lam GK; Oelfke U; Gardey K; Durand RE; Skarsgard LD
    Radiat Res; 1996 Aug; 146(2):159-70. PubMed ID: 8693066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.